TBC1D3C Antibodies

Santa Cruz Biotechnology features a diverse variety of TBC1D3C monoclonal antibodies for investigating TBC1D3C's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D3C belongs to the TBC (Tre-2/Bub2/Cdc16) domain family and plays a significant role in regulating cellular signaling pathways and vesicle trafficking. Research has shown that TBC1D3C influences insulin signaling and glucose homeostasis, making it a key component in metabolic regulation. Scientists studying TBC1D3C have uncovered its involvement in various metabolic conditions, including diabetes and obesity. Investigating TBC1D3C function continues to reveal new insights about cellular regulation and disease mechanisms. Research focused on TBC1D3C has expanded our understanding of cellular signaling networks and their impact on human health. Understanding TBC1D3C's role in metabolism opens new possibilities for therapeutic interventions in metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge and potentially develop new treatments for metabolic diseases.